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Abstract
Background: TIR-domain-containing adapter-inducing interferon-b (TRIF) is the sole downstream adaptor of Toll-
like receptor (TLR)3, which is one of the major signaling pathways in immune cells leading to neuroinflammation
in the central nervous system. Overexpression of TRIF may lead to activation of inflammatory responses, and
contribute to pathophysiological progression in both acute and chronic neurodegenerative retinal diseases. In the
present study, was aimed to elucidate the contributions of TRIF to optic nerve (ON) regeneration and retinal
ganglion cell (RGC) survival following injury to the ON, a widely studied model of central nervous system injury
and of degenerative diseases such as glaucoma.
Methods: We used retrograde labeling with a fluorochrome, hydroxystilbamidine (Fluorogold) to evaluate RGC
survival, and immunostaining with growth-associated protein-43 to evaluate axon regeneration in an ON crush
model. Changes in microglial cytokines following RGC injury was examined with ELISA and real-time PCR. In vivo
studies were carried out in wild-type and trif
-/- mice. A Transwell co-culture system and migration test were used
to mimic the crosstalk between microglia and RGCs. TRIF-associated downstream adaptors were determined by
western blotting.
Results: Compared with wild-type (WT) mice, TRIF knockout (KO) mice displayed a robust ability to regenerate
axons 3 or 7 days after nerve injury. In addition, RGC survival was considerably higher in trif
-/- than in WT mice. ON
lesion induced less microglial activation in trif
-/- than in WT mice. and more WT microglia distorted and migrated
toward the foramen opticum. In the transwell system, few trif
-/- microglia migrated through the membrane when
stimulated by the performed lesion on RGC axons in a transwell system. Inactivation of microglial cells in trif
-/- mice
was associated with reduced production of inflammatory cytokines, as detected with real-time RT-PCR and ELISA.
Furthermore western blot analysis showed that activation of known downstream effectors of TRIF, including TBK1,
IKKε and NF-B, were significantly inhibited by TRIF deficiency.
Conclusion: Our results indicate that TRIF deficiency promotes ON axon regeneration by attenuating microglial
activation and consequently reducing the release of harmful cytokines via NF-B inactivation.
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Axon regeneration in the central nervous system (CNS)
is limited by both cell-intrinsic and environmental inhibi-
tory molecules [1-4]. The optic nerve (ON) crush model
is considered to be a classic model for studying CNS
regeneration [4-9]. Microglia act as tissue macrophages
i nt h eC N S ,t h u st h e yp l a yar o l ei nt i s s u em a i n t e n a n c e
and immune surveillance [10], and become activated
under pathological conditions, including neurodegenera-
tive diseases and neural injury [11,12]. There is increasing
evidence that inflammatory factors, such as interleukins
(ILs), tumor necrosis factor (TNF)-a, and nitric oxide
(NO), released by activated or over-activated microglial
cells [13-15], affect neural cell survival [1,16]. Pro-inflam-
matory cytokines are produced largely in response to
Toll-like receptor (TLR) activation in microglial cells.
In the CNS, TLRs are mainly found on immune cells,
such as microglia and macrophages [17-20]. An alterna-
tive downstream adaptor, TRIF, is recognized as the sole
transducing signal in the TLR3 signaling pathway in
response to double-stranded RNA. The TLR4 signaling
pathway acts via a myeloid differentiation factor (MyD)
88 -independent pathway, leading to the subsequent
activation of nuclear factor (NF)-B and interferon regu-
latory factor (IRF)3, which induces interferon (IFN)-b
release [21]. In an ischemia-reperfusion model, we pre-
viously found that high mobility group protein (HMG)
B1 mediates injury via TRIF-independent TLR4 signal-
ing [22]. However, the involvement of MyD88 or TRIF
may differ in different tissues and cells. Dual signaling
of MyD88 and TRIF is crucial for dendritic cell matura-
tion [23]. The TLR3/TRIF signaling pathway is required
for apoptosis of melanoma cells by polyinosinic-polycy-
tidylic acid (poly I:C)-induced activation of caspase-8
[24]. TLR3/TRIF/receptor-interacting protein (RIP)1 sig-
naling is also essential for human airway epithelial cells
apoptosis via caspase-mediated activation [25]. However,
the role of TRIF in neural apoptosis and axonal degen-
eration/regeneration remains unclear. The current study
was designed to determine the potential role of TRIF in
ON injury and retinal ganglion cell (RGC) survival, and
the downstream mechanisms involved.
We found that trif
-/- mice exhibit increased retinal
axon regeneration and less RGC loss compared with
wild-type (WT) mice. Our results indicate that TRIF
deficiency attenuates microglial activation and down-
stream signaling, and limits the release of inflammatory
cytokines following ON injury.
Methods
Animals
All animal-related procedures in this study were in strict
accordance with the Third Military Medical University
(TMMU) guidelines for the use of experimental animals.
The Animal Ethics Committee of TMMU approved all
experimental procedures used in the present study.
SPF grade adult male C57BL/6 male mice (20-24 g)
(Animal Center, Third Military Medical University,
Chongqing, China), and male trif
-/- mice (C57BL/6 J-
AW046014
Lps2/J; (Jackson Laboratory, Bar Harbor, ME,
USA), aged 8-10 weeks (20-24 g) of age, were used. All
mice were housed on a 12 hour light/dark schedule with
water and food available ad libitum. Neonatal C57BL/6
mice were used to make primary microglial cultures.
Optic nerve crush model
The ON is considered a classic model of CNS regenera-
tion to investigate injury [4,6-9]. ON crush was carried
out as described previously [7]. In brief, adult WT
C57BL/6 mice and trif
-/- mice were anesthetized with
intraperitoneal (IP) injection of chloral hydrate in PBS
(400 mg/kg), and the ON was crushed as described
[4,6,7]. Animals with permanent ischemia were
excluded. All procedures were performed aseptically and
o nt h el e f te y e ,w i t ht h er i g h te y es e r v i n ga sas h a m -
operated control.
Fixation and sectioning
Animals were killed at the end of the treatment period
with intraperitoneal injection of chloral hydrate in PBS,
perfused through the heart with 0.9% saline, followed by
4% paraformaldehyde (PFA). The eyes were removed
a n dp o s t - f i x e di n4 %P F Af o r4h o u r sa t4 ° C ,a n dt h e n
incubated in 30% sucrose overnight at 4°C. The eye
cups and ONs were cryosectioned into slices 15 μm
thick on a rapid sectioning cryostat (CM 1900 Leica and
thaw-mounted onto coated glass glides (Superfrost Plus,
Fisher, Pittsburgh, PA, USA).
Retinal ganglion cell and microglial cell culture
RGCs were purified from the retinas of trif
-/- and WT
mice on post-natal day 1 by immunopanning, as pre-
viously described [26]. Axon outgrowth and cell survival
in serum-free DMEM (Sigma, St. Louis, MO, USA) were
assessed after maintaining the plate at 37°C for 3 days.
As previously described [6], axon growth was defined as
the percentage of RGCs that extended axons of no less
than two cell diameters in length.
For microglia culture, the cortex of the cerebral hemi-
spheres of 1-day-old post-natal mice were dissected, and
digested with 0.125% trypsin. After centrifugation for 5
minutes at 300 × g, the lower precipitation products
were seeded onto a six-well plate pre-coated with poly-
L-lysine, and incubated with DMEM and 10% FBS
(Hyclone, Logan, UT, USA). Culture medium was
refreshed twice a week for 2 weeks, and the microglia
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nylon mesh to remove astrocytes. After centrifugation at
300 × g for 5 minutes, the cells were resuspended in
fresh DMEM supplemented with 10% FBS and plated at
a final density of 5 × 10
5/ml cells on a poly-L-lysine
pre-coated six-well culture plate. Cell purity was deter-
mined by immunohistochemical staining with microglia-
specific antibodies for CD11b and F4/80, and purity was
determined to be > 90%.
Antibodies and immunofluorescence staining
Tissue sections were rinsed in 0.01 mol/l PBS, and then
incubated in 5% normal donkey serum diluted in PBS
for 1 hour at 25°C. Following removal of serum, tissue
sections were incubated overnight with primary antibo-
dies. An antibody to growth-associated protein (GAP)43
was used to label regenerated axons within the ON
(1:1000, sheep anti-mouse; supplied by Prof. Y. Yin).
Rabbit polyclonal antibody to TRIF (1:200 dilution; cata-
logue number ab13810; Abcam, Cambridge, Cambridge-
shire, UK) was used to visualize TRIF. CD11b (1:200;
14-0112-81; eBioscience, San Diego, CA, USA) and Iba-
1 (1:50; 15690; Abcam) were used as a marker for
microglia. On the second day, the sections were washed
in PBS and then incubated with secondary antibody for
1 hour at 25°C. Fluorescent secondary antibodies were
used to visualize the primary antibody staining: goat
anti-rat Alexa Fluor
® 488 (A11006, 1:300), goat anti-rab-
bit Alexa Fluor
® 568 (A11011, 1:300), and donkey anti-
sheep Alexa Fluor
® 568 (A21099, 1:300) all Invitrogen
Corp., Carlsbad, CA, USA). Sections incubated with pre-
immune rabbit IgG (17-615, Millipore, USA) served as a
negative control. After washing with PBS, sections were
stained with 4’, 6-diamidino-2-phenylindole (DAPI, 0.5
μg/ml) for 10 minutes at 25°C and then rinsed with
PBS, and mounted with a fluorescent mounting medium
(DAKO Cytomation, Glostrup, Denmark). Co-localiza-
tion of TRIF and IBA1 were examined under a confocal
microscope (LSM FV1000; Olympus Company Pte Ltd,
Tokyo, Japan).
For retinal flat-mounts, eyes were removed and post-
fixed in 4% PFA for 30 minutes. Retinas from the intact
right eyes of the same animals were used as normal con-
trols. After three washes in PBS, retinas were blocked
and permeabilized using 5% goat serum (Hunter Anti-
sera, New South Wales, Australia) and 0.2% Triton X-
100 for 1 hour at 25°C, and then incubated with CD11b
(1:200; 14-0112-81; eBioscience) and a bIII-tubulin anti-
body (1:500; Babco, Richmond, CA, USA) for 2 days at
4°C. The next day, retinas were rinsed with PBS, then
incubated with a goat anti-rabbit Alexa Fluor
® 568 sec-
ondary antibody (1:300, Invitrogen) at 4°C overnight,
rinsed again, and overlaid with a coverslip in mounting
medium.
Cells were fixed with 4% PFA at 25°C for 30 minutes,
then blocked with 5% bovine serum albumin (BSA,
Sigma-Aldrich, St Louis, MO, USA) for 30 minutes at
25°C. The cells were incubated with primary antibody
(GAP43, 1:1000) for 1 hour at 25°C, followed by over-
night incubation at 4°C. The next day, cells were
exposed to secondary antibody (Alexa Fluor
® 568-conju-
gated donkey anti-sheep IgG (H + L), 2 mg⁄mL, Invitro-
gen) for 1 hour at 25°C. Axon outgrowth was evaluated
in quadruplicate samples (~20 RGCs per well) in a
blinded fashion, and all experiments were repeated at
least three times, independently.
Retinal ganglion cell axon retrograde labeling
WT and trif
-/- male mice were anesthetized and placed
in a stereotactic apparatus (Stoelting, Kiel, WI, USA).
The skull was exposed and cleaned with 3% hydrogen
peroxide. A hole 1 mm in diameter was drilled in the
skull (4.0 mm posterior and 0.06 mm lateral to the
bregma), and a 26-gauge stainless steel cannula was
inserted for infusion of a fluorochrome, hydroxystilba-
midine (Fluorogold; Biotium, Inc., Hayward, CA, USA)
infusion (1 μl/10 min). One week before ON lesion. 1 μl
of 4% Fluorogold (FG) was injected into the bilateral
superior colliculus (1.2 mm deep from the skull)
Analysis of axon regeneration and Fluorogold-labeled
retinal ganglion cells
Analysis of axon regeneration and RGC survival were
conducted in accordance with a previous report [6].
Briefly, regenerating axons were examined using a cali-
brated ocular to measure distance in five longitudinal
sections of the ON by GAP43 immunostaining; 8 to 10
sections per animal were used in the quantification. A
researcher blinded to the sample identity quantified
axon growth by counting the total number of GAP43-
positive axons arising from RGCs at various distances
past the lesion site (100, 200, 300, 400, and 500 μm
from the end of the crush site). The calculation of axon
quantification was conducted in accordance with the
method of Yin [4]. Axon counts were converted into
axon crossings (axons/mm), and the mean over the five
sections was calculated. Σad, defined as the total number
of axons extending distance d i nao p t i cn e r v ew i t ha
radius of r, was estimated by summing over all sections
of thickness t as follows:

ad = πr2 × (average axons/mm width)/t
Total axon number was calculated in each case. Ana-
lysis of variance (ANOVA) was used to test the signifi-
cance of the differences between groups. To analyze the
survival number of RGCs in whole retinas labeled with
FG at 0, 1, 3, and 7 day post-crush (dPC), the gold dots
Lin et al. Journal of Neuroinflammation 2012, 9:39
http://www.jneuroinflammation.com/content/9/1/39
Page 3 of 15(surviving RGCs) were counted using Image Pro Plus
(version 6.0, Media Cybernetics, Inc., Bethesda, MD,
USA).
Western blotting
For cultured microglia or neurons, cells were washed in
sterile PBS, then lysed in 2% SDS (in deionized water)
with a protease inhibitor cocktail (118836153001; Roche
Diagnostics, Indianapolis, IA, USA) at a concentration of 1
×1 0
6 cells/mL. The lysate was then separated by centrifu-
gation at 12000 g at 4°C for 15 minutes. The supernatant
was collected and the protein concentration was measured
using a bicinchoninic acid protein assay (Pierce, Rockford,
IL, USA); 35 μg samples were loaded into 8% SDS-polya-
crylamide gels. Proteins were then transferred to polyviny-
lidene difluoride membranes (Millipore Corporation,
Bedford, MA, USA) using a 100 V current for 1.5 hours.
The blots were then first washed with Tris-buffered saline
and Tween (TBS-T; 50 mmol/L Tris pH 7.4, 150 mmol/L
NaCl, and 0.1%Tween), followed by blocking in 5% non-
fat milk-TBS-T overnight at 4°C. Antibodies recognizing
NF-B (1:500, AN365, Beyotime, China), TANK-binding
kinase (TBK)1 (1:500; ab40676; Abcam, Cambridge, UK),
IB kinase (IKK)ε (1:1000; LS-B63; Lifespan, Seattle, WA,
USA), and GAP43 (a gift from Yin [4]) were made up in a
solution of in 5% milk in TBS-T, and used overnight at 4°
C, followed by three washes with TBS-T and incubation
with horseradish peroxidase-conjugated anti-rabbit, anti-
sheep or anti-rat IgG secondary antibodies (Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA) in TBS-T for
1.5 hours at 25°C. The blot was developed with DAB and
a commercial chemiluminescent detection system (Super-
Signal
® West Pico Chemiluminescent Substrate Detection
System; Thermo Fisher Scientific Inc., Rockford, IL, USA).
Tissue collection and cytokine measurement
Real-time reverse transcriptase PCR analysis
To analyze the mRNA expression of cytokines, total
RNA extraction and real-time PCR were performed as
previously reported, with minor modifications [27].
Total RNA was extracted (RNA IsoPlus, TaKaRa Bio-
technology Co. Ltd, Dalian, China) with 800 μlo ft h e
RNA lysis buffer supplied with the kit. RNA was
reverse-transcribed (TaKaRa PrimeScript RT Reagent
Kit; TaKaRa Biotechnology Co. Ltd) in accordance with
the manufacturer’s instructions. First-strand cDNAs
were amplified using a real-time PCR thermal cycler
(IQ5; Bio-Rad Laboratories, Inc., Hercules, CA, USA).
Quantificative real-time PCR was performed with Taq
polymerase (SYBR Premix Ex Taq II; TaKaRa Biotech-
nology Co. Ltd) in accordance with the manufacturer’s
instructions. Primers for IFN-b, b-actin, TNF-a, induci-
ble NO synthase (iNOS), IL-1b, IL-6, and IL-17 (Sangon
Biotech, Shanghai, China) are shown in Table 1. For
relative comparison of each gene, we analyzed the cycle
o ft h r e s h o l d( C t )v a l u eo fr e a l - t i m eP C Rd a t au s i n gt h e
-ΔΔCt method, in accordance with the company’s
instructions.
ELISA analysis
Microglial cells were collected at 12, 24, and 36 hours
after stimulation of injured RGCs. The cells were rinsed
twice with PBS, and then lysed with a protease inhibitor
cocktail (Roche Complete, Roche Diagnostics, Man-
nheim, Germany), and frozen at -80°C until analysis. For
protein isolation, the samples were milled and separated
by centrifugation at 10, 621 × g at 4°C for 10 minutes.
The supernatant was carefully pipetted into a fresh 1.5
ml EP Eppendorf tube, and the protein concentration
was evaluated by protein assay (BCA Protein Assay Kit;
Beyotime, China). For TNF-a,I F N - b,I L - 1 b IL-6, and
IL-17 detection, a mouse ELISA kit (R&D Systems, Min-
neapolis, MN, US) was used, in accordance with the
manufacturer’s instructions. Briefly, the plate was incu-
bated with 100 μl of each sample or standard protein, in
duplicate. After incubation and subsequent washing,
horseradish peroxidase-conjugated streptavidin at 400
ng/ml detection antibody was added, followed by wash-
ing and incubation with the substrate solution provided
with the kit to produce a color reaction, which was
stopped by addition of stop solution. The absorbance
was read at 450 nm in a microplate reader.
Statistical analysis
Statistical analyses were performed to evaluate the dif-
ferences between experimental and control groups. We
used one-way ANOVA (Figures 1A, 2B-D, 3B, C, 4D, E,
5C, E, 6A-K and 7A-K), method and two-way ANOVA
(Figure 5B). Data are presented as mean ± SD, with sig-
nificance was set at P <0 . 0 5( *i nf i g u r e s )a n dP <0 . 0 1
(** in figures). Graphics and calculations were performed
using Graph Pad PRISM (version 5.0 GraphPad Inc. La
J o l l a ,C A ,U S A ) ,a n dS P S Ss o f t w a r e( v e r s i o n1 5 . 0 ;S P S S
Inc., Chicago, IL, USA).
Results
Expression of TIR-domain-containing adapter-inducing
interferon-b in wild-type retinas 1, 3, and 7 days post-
crush
TRIF is the unique adaptor of TLR3, which is expressed
in microglia and presumably acts as an intracellular
TLR-bound molecule. TRIF is important for TLR signal
transition [21]. When the ON was injured, TRIF was
unregulated from PC day 1-7 in the retina, in a time-
dependent manner. At days 3 and 7 PC especially, TRIF
expression was significantly higher than in the sham and
day 1 PC group independently (Figure 1A, n = 4, P <
0.05). Using dual-label immunofluorescence staining, co-
expression of TRIF and Iba-1 was detected in microglia
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express specific TRIF when the optic nerve is injured
(Figure 1B).
TIR-domain-containing adapter-inducing interferon-b-
deficient mice exhibit robust axon regeneration ability
The GAP43 antibody was used to evaluate the newly
outgrown axons from soma, as described previously [4],
We observed significant axon regeneration in trif
-/-
mice, and trif
-/- RGCs exhibited robust regenerative abil-
ity after lesion, in contrast to WT RGCs (Figure 2A).
On day 1 PC, GAP43-labeled axons stopped at the
crush site, with no labeled fibers found distal to the
crush site, either in the WT or trif
-/-groups. On days 3
and 7, the mean estimated numbers of outgrown axons
(100 μm distal to lesion site) were 392 ± 66 and 542 ±
49, respectively (n = 6, Figure 2B, C) in trif
-/- RGCs,
whereas much less axon outgrowth was visible in the
WT group (Figure 2A). This result partly correlated
with a previous study, which reported observation of
numerous axonal sprouts on day 3 PC in phosphatase
and tensin homolog (PTEN)-deleted mice [9].
Axon regeneration and survival in retinal ganglion cells in
vitro are independent of TIR-domain-containing adapter-
inducing interferon-b deficiency
To determine whether the deficiency of TRIF has any
effect on the ability of RGCs to promote axon regenera-
tion, RGCs were separated from the retina using serum-
free neural basal medium to evaluate the ability of RGC
regeneration. Three days after culture, we quantified the
mean length of axons positively labeled with GAP43.
T h em e a na x o nl e n g t ho fR G C sw a s1 4 . 8±1 . 3μmi n
trif
-/-mice (n = 9) and14.5 ± 1.7 μmi nW Tm i c e( n=
9), with no significant difference between the groups
(Figure 2D). To evaluate the survival ability, we
scratched the cultured RGCs on the plate to mimic the
in vivo lesion model, and found that there was no differ-
ence in the survival ratios of trif
-/- and WT RGCs (n =
14, P < 0.05, data not shown).
TIR-domain-containing adapter-inducing interferon-b
deficiency prevents optic nerve loss
With bIII-tubulin staining, we were able to observe
RGCs and optic nerve bundles in vivo in whole-mount
retinas. The width and density of nerve bundles were
Table 1 Primers used in the experiments
Gene Ref. Sequences Accession Forward (5’-3’) Reverse (5’-3’)
b-actin NM_007393.3 AGATTACTGCTCTGGCTCCTAGC ACTCATCGTACTCCTGCTTGCT
IL-1b NM_008361.3 TCCAGGATGAGGACAT GAACGTCACACACCAGCAGGTTA
IL-6 NM_031168.1 GAGGATACCACTCCCAACAGACC AAGTGCATCATCGTTGTTCATACA
IL-17 NM_010552.3 ACGCGCAAACATGAGTCCAG AGGCTCAGCAGCAGCAACAG
iNOS NM_010927.3 AATTCGGCTGTGCTTTGATGG GACTTGCGGGAGTCAGAATAGGAG
IFN-b NM_010510.1 AAGCAGCTCCAGCTCCAAGAA TTGAAGTCCGCCCTGTAGGTG
TNF-a NM_013693.2 TCCAGGCGGTGCCTATGT CGATCACCCCGAAGTTCAGTA
IFN, interferon; IL, interleukin; iNOS, inducible NO synthase; TNF, tumor necrosis factor.
ɴċ-Tubulin
GFAP
IBA1 TRIF
TRIF
TRIF
DAPI
DAPI
DAPI
Merged
Merged
Merged
A
B
66kD
36kD
*
*
6KDPG3&G3&G3&
TRIF
ȕ-actin
66kD
42kD
*
*
6KDPG3&G3&G3&
Sham   1dPC    3dPC    7dPC
Time (day)
Sham   1dPC     3dPC    7dPC
Time (day)
Figure 1 TIR-domain-containing adapter-inducing interferon-b
(TRIF) is expressed by microglia, but not by astrocytes or
neurons, and is expressed in a time-dependent manner.( A)
Retinas were collected from sham-operated mice and from TRIF-
deficient mice at 1, 3, and 7 days post-crush (1dPC, 3dPC, and 7dPC,
respectively). TRIF expression was examined by western blotting,
which showed that in the sham-operated and 1dPC groups, TRIF
expression was limited. At 3dPC and 7dPC, TRIF expression was
upregulated. GAPDH and b-actin were used as internal controls. *P
< 0.05, increase relative to sham control. (B) Using dual-label
immunofluorescence staining, expression of TRIF was detected in
microglia but not neurons and astroglia. Iba-1, bIII-tubulin and glial
fibrillary acidic protein (GFAP) were used to identify microglia,
neurons, and astroglia in retinal sections. Scale bar = 20 μm. Scale
bar (in box) = 10 μm.
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-/- and WT mice by
d a y2 8P C .T h ed e n s i t yo fR G C sa n dt h et h i c k n e s so f
nerve bundles were higher in the retinas of trif
-/- mice
compared with WT mice (Figure 3A). Using Image Pro
Plus software, the width of the nerve bundle was ana-
lyzed, with a mean width of 10.38 ± 0.76 μmf o u n di n
the trif
-/- group (n = 26) and 4.24 ± 0.81 μmi nt h eW T
group (n = 30, Figure 3B). rONB was 262 ± 18 (n = 26)
in the trif
-/- group, which was greater than that of the
WT group (198 ± 3, n = 30, Figure 3C), indicating that
ONs without TRIF were resistant to neural atrophy.
TIR-domain-containing adapter-inducing interferon-b-
deficient mice found higher survival rates after optic
nerve lesion
Before the lesion operation, RGS axons in the soma
were retrograde-labeled with FG in control retina (Fig-
ure 4A). The animals bred, and the survival rate was
100%. In the ON lesion groups, fewer RGCs remained
visible with FG labeling from day 7-21 PC in both
groups (Figure 4B, C). All the labeled RGCs were gold
in color, and characteristically round or oval under UV
microscopy while they were alive. Quantitatively, the
mean number of surviving RGCs on days 7, 14 and 21
PC were 1010 ± 321, 867 ± 151, and 726 ± 89, respec-
tively, in the trif
-/- retina, (six RGCs per field; P< 0.05;
Figure 4C, D)and 452 ± 98, 326 ± 120, and 312 ± 115,
respectively, in the WT group (n = 6; Figure 4B, D).
The survival rateswere 69.25 ± 4.03%, 56.75 ± 1.75%
and 49.75 ± 3.33%, respectively, for trif
-/- retina, (Figure
4E), which was higher than those of the WT group
(51.75 ± 4.68%, 30.25 ± 3.43%, 25.00 ± 2.80%, n = 6, P
<0.05), indicating that TRIF deficiency protects the
retina from RGC apoptosis or necrosis.
Optic nerve lesion induced microglial activation in wild-
type but not trif
-/- animals, both in vivo and in vitro
In the adult retina, ramified microglial cells are found in
both the inner and outer plexiform layers. CD11b, a
microglial marker, was used to identify the activated and
Figure 2 TIR-domain-containing adapter-inducing interferon-b deletion promotes optic nerve regeneration. (A) Longitudinal sections
through an optic nerve immunostained to detect growth-associated protein43-positive axons distal to the injury site (*) at 0, 1, 3, 7 and 28 days
after nerve crush. The trif
-/- mice exerted more robust regeneration ability than the wild-type (WT) mice. In WT mice, few axons were
regenerated beyond the lesion site (*), in contrast to the trif
-/- group, in which regeneration was particularly marked at 28 days post-crush
(28dPC). Upper scale bar = 100 μm, bottom scale bar = 50 μm. (B) Estimated number of regenerated fibers (> 100, 200, 300, 400, and 500 μm
from the lesion site) at 3dPC and (C) 7dPC in the WT and trif
-/- groups. *P < 0.05, **P < 0.01, increase relative to WT. (D) Quantification of
outgrown axons of in vitro retinal ganglion cells (RGCs) by GAP43 immunostaining. Axon length was calculated by two observers using a
double-blinded method, under a microscope. Mean length of axons was measured using a micrometer.
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that in whole-mount retina immunostaining, the micro-
glia was ramified, surrounded by fine protractions. How-
ever, after 7 dPC, the microglia formed a dotted or short
ramified shape in the WT retina, but not in the trif
-/-
retina. At 14 d PC, the WT microglia had migrated
towards one pole (foramen opticum) with dot or amoe-
boid shape to the body, whereas the trif
-/- microglia did
not exhibit directivity (Figure 5A). From 14 dPC, the
number and density of microglia increased in the sham-
operated groups of both trif
-/- and WT retina (Figure
5B). Statistical analysis indicated that at 7 dPC, the esti-
mated number of activated microglia in was 174 ± 28/
mm
2 in the trif
-/- retina and 189 ± 24/mm
2 in the WT
retina, which had increased to 29 ± 11/mm
2 in the trif
-/-
group and 242 ± 32/mm
2 by 14 dPC (n = 6, P > 0.05,
Figure 5B). No significant difference was seen between
the trif
-/- and WT groups at the same time points, but
differences were identified between different time points
(sham, day 7, and day 14 for both trif
-/- and WT, P
<0.05). In addition, there was little difference between
the retinas of the trif
-/- a n dW Tg r o u p sa t1a n d3 d P C
(data not shown).
We examined microglia migration by placing the
microglia in the transparent polyester membrane of a
transwell plate, with RGCs in the lower well of the
plate. On the first day after lesion, we observed axonal
outgrowth from the soma in the co-culture group.
Meanwhile, in accordance with the axon lesion in the
lower well, the upper microglia migrated across the
transwell membrane (Figure 5E). The number of
migrated migroglia was 217 ± 34/cm
2 in the trif
-/- (n =
6) group and 439 ± 41/cm
2 (n = 6) in the WT group,
with the trif
-/- microglia having a lower migration ability
than the WT microgliatowards the lesioned RGCs in
vitro.
At 7dPC in the WT retinas, Iba-1 was expressed in
the inner plexiform layer (IPL) and ganglion cell layer
(GCL), but it seemed that fewer microglia migrated into
the trif
-/- retinas in transected sections (Figure 8A, B).
The trif
-/- microglia had more processes, and a ramified
shape. At 14 dPC, more microglia had migrated into the
GCL and IPL in WT retina than in trif
-/- retina, and the
former had a dotted or short ramified shape, suggesting
that TRIF deletion attenuates the microglial activation.
TIR-domain-containing adapter-inducing interferon-b
deficiency attenuates inflammation via TANK-binding
kinase (TKK)1/IB kinase (IKK)ε and nuclear factor (NF)-B
signaling
The activation of microglia suggests that these cells
would be responsive to injured RGCs. To assess the
relevant downstream signal of TRIF, we determined the
expression of TBK1, IKKε,a n dN F - B signaling. In a
transwell co-culture system, microglial responses to
RGC axon lesion mimicked the optic nerve crush model
in vivo. Time-course studies were performed on trif
-/-
microglia using western blot analysis, and compared
with the WT. The protein levels of b-actin (the internal
control) remained largely unchanged in both control
and stimulated cells. TBK1 was upregulated between 12
hours and 36 hours in the WT group, whereas did the
maximum TBK1 expression was reached in the trif
-/-
group by 12 hours. The WT and trif
-/- groups had dif-
ferent time-dependent behaviors (Figure 7). Accompany-
ing the increase in IKKε expression, NF-Bw a s
increasingly expressed during the period from 0 to 36
hours. However, the trif
-/- group had significantly differ-
ent time-dependent behavior; from 12 hours to 36
hours, the expression of NF-B decreased gradually and
IKKε expressed steadily, suggesting that TRIF deficiency
Figure 3 Optic nerve bundles in whole-mount retina by bIII-
tubulin immunostaining.( A) Optic nerve bundles (ONBs) were
immunostained with bIII-tubulin and DAPI. In both the WT and trif
-/-
sham groups, ONBs displayed a regular and full shape. At 4 weeks
post-crush (4wPC), both WT and trif
-/- ONB became attenuated; this
was especially marked in the WT retina, which seems atrophic.
Using double-blinded quantification, (B) WT retina were found to
display narrower ONBs (B, n = 26) and (C) had a lower value (rONB;
n = 30) compared with those in the trif
-/- group.*P < 0.05, **P <
0.01, Scale bar = 50 μm.
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consistent with those of Chang et al. [29].
Expression of inducible nitric oxide synthase, tumor
necrosis factor-a, interferon-b, and interleukins-1b, 6 and
17 decrease in trif
-/-microglial cells after axonal lesion
To determine whether the decreased expression of
TBK1/IKKε and NF-B proteins leads to changes in
inflammatory factors, we next characterized the expres-
sion of iNOS, TNF-a,I F N - b,I L - 1 b, IL-6, and IL-17 by
quantitative (q)PCR in microglial cells and the superna-
tant of conditioned medium that was pre-stimulated by
injured RGCs for 12, 24, and 36 hours. The housekeep-
ing gene b-actin and the genes for the inflammatory
protein iNOS, TNF-a,I F N - b,I L - 1 b, IL-6, and IL-17
were amplified for 40 cycles. Expresion of TNF-a, IL-17,
and IFN-b mRNAs were significantly lower in the trif
-/-
group than in the WT group, especially for the pre-
stimulation group at 36 hours (Figure 6A, C, E). The
upregulation of these mRNAs was time-dependent in
the pre-stimulated time course. However, in the WT
group, there was a marked increase in expression at 36
hours for iNOS, TNF-a,a n dI F N - b (Figure 6A, C, F),
a n da t2 4h o u r sf o rI L - 6 ,I L - 1 b,a n dI L - 1 7( F i g u r e6 B ,
D, E). In the trif
-/- group, the expression of iNOS and
IL-17 did not significantly differ from the control up to
36 hours. However, TNF-a and IL-6 were upregulated
at 12 and 24 hours, and then downregulated at 36
hours. The most interesting factor was IL-1b,w h o s e
expression reached a maximum (6.8 times that of the
WT maximum) at 12 hours and decreased suddenly at
24 hours (43.5% of WT) and 36 hours (46% of WT) in
the trif
-/- group.
To determine the release of inflammatory factors in
the microglial cell supernatant that was pre-stimulated
with injured RGCs, we performed ELISA detection.
Figure 4 Retinal retinal ganglion cell (RGC) survival detected by Fluorogold (FG) retrograde labeling.( A) FG was transported retrograde
to RGC soma in a whole-mount retina used as a control. From 7 to 21 days post-crush (7dPC to 21dPC, FG-labeled RGCs declined in (B) the WT
and (C) trif
-/- groups. Scale bar, 100 μm. The number of labeled RGCs was analyzed to confirm that more RGCs survived in the trif
-/- group than
in the WT group (D). *P < 0.05 vs. WT group. (E) Survival ratio of RGCs in trif
-/- group was higher than that in the WT group from 7dPC to
21dPC. *P < 0.05 vs. WT group.
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Page 8 of 15Figure 5 Microglial activation in whole-mount retina and microglial migration in an in vitro model.( A) Microglia in wild-type (WT) retina
have a different shape from those in the trif
-/- group as shown by CD11b immunostaining at 7 and 14 days post-crush (7dPC and 14dPC). Scale
bar = 20 μm. (B) Estimated numbers of microglia/mm
2 in whole-mount retinas were different between different time-course groups (*P < 0.05
increase relative to sham and 14dPC group). (C) Estimated number per mm
2 of microglia with an amoeboid shape in whole-mount retinas were
different between wild-type (WT and trif
-/- groups at 7 and 14 days post-crush (7dPC and 14dPC). *P < 0.01 increase relative to WT group in
7dPC and 14dPC. (D) Outline of whole-mount retina. Square frames (red) were counted using double-blinded quantification. (E) In a transwell
system, microglia and retinal ganglion cells (RGCs) were cultured together (as shown in drawing). Microglia became activated and migrated to
the other side of the membrane when stimulated by injured RGCs in the lower well. Stained with cresyl violet acetate. Scale bar = 20 μm.
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Page 9 of 15Similar to the qPCR results for TNF-a,I F N - b,I L - 1 b,
IL-6, and IL-17 the change in the inflammatory factor
levels depended on pre-stimulation time course and
TRIF deficiency (Figure 6G-K). In the WT group,
release of TNF-a and IFN-b gradually increased from 0
to 36 hours, and were significantly higher than those of
the trif
-/- group at 36 hours. Protein levels of IL-6 and
IL-17 were much higher in the WT than the trif
-/-
microglial cells at 24 and 36 hours. By contrast,
increased IL-1b was detected at 12 hours in the trif
-/-
group but not in the WT group, and it rapidly
decreased to a lower level by 24 and 36 hours compared
with the WT group.
Discussion
I nt h er e t i n a ,o x i d a t i v es t r e s si n d u c eb yt r a u m a ,r e t i n a l
neovascularization, and sterile inflammation may contri-
bute to various eye diseases, including retinal ischemia
and glaucoma [30]. As a CNS neuron, the optic nerve
cannot regenerate after injury [1,2], except in certain
special situations, such as in the case of oncomodulin
stimulation [26], Mst3b-mediating axon regeneration
[31], and intrinsic axon regeneration regulated by the
Kruppel-like factor family [32]. TLR signaling is crucial
for functional recovery after peripheral nerve injury [33]
a n do p t i cn e r v ei n j u r y[ 3 4 ] .I nt h ep r e s e n ts t u d y ,w e
found that TRIF gene ablation exerted a positive effect
on the regeneration of the ON, which is a classic model
for studying the CNS. Statistical analysis verified that
the process of recovery was different between TRIF-suf-
ficient and -deficient groups.
Using GAP43 staining, we found that by 7 dPC, TRIF
deficiency exerted a significant effect on longer regenera-
tive axons compared with the WT group, which is similar
to the results described by Yin et al. [4]. This suggests an
unexpectedly powerful neuroprotective effect of TRIF
deficiency in microglial cells. One hypothesis to explain
this is that in the adult CNS, the capacity for axon out-
growth is reduced by intrinsic factors; however, the mole-
cular nature of this reduction is still unclear [35]. In our
results, adult trif
-/- mice had the ability to regenerate
axons in the ON. However, the in vitro results showed
that trif
-/- RGCs cultured solely with serum-free medium
had the same limited regeneration ability as WT RGCs
(Figure 2D). In addition, TRIF was not expressed in WT
RGCs. The results indicated that TRIF is not an inhibi-
tory molecule that limits the regenerative ability of retinal
axons. GAP43 is a membrane phosphoprotein that is
normally undetectable in the mature ON, but is strongly
expressed in axons undergoing regeneration [36]. In
adult mice, we found that trif
-/- RGCs were unable to
regenerate axons on their own, without interaction with
the microenvironment.
The in vivo ON lesion model and the in vitro RGC
culture produced different results for the regenerative
ability of WT and trif
-/- RGCs, indicating that the
microenvironment plays some role in the regenerative
ability of the RGCs. To explore the effect of TRIF, we
used a dual-label immunochemistry method on retinas.
We found that astrocytes and neurons did not express
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Figure 6 TIR-domain-containing adapter-inducing interferon-
&#946 (TRIF) deficiency attenuates inflammation via TANK-
binding kinase (TBK)1/I&#954B kinase (IKK)&#949 and nuclear
factor (NF)-&#954B signaling. Western blot results for wild-type
(WT) and trif-/- microglia pre-stimulated by injured retinal ganglion
cells (RGCs) in a transwell system identifies the signaling changes
downstream of TRIF. (A) Bar graph showing that TBK1 was
upregulated gradually in the WT group; however, trif-/- effectively
suppressed TBK1 from 24 to 36 hours. (B) Trif-/- effectively
suppressed NF-&#954B from 12 to 36 hours. (C) Bar graph showing
that trif-/- effectively suppressed IKK&#949 from 12 to 36 hours. *P
<0.05, **P <0.01 vs. WT group at the same time point. &#946-Actin
was used as an internal control.
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Page 10 of 15TRIF, but microglia did (Figure 1B). As a downstream
adaptor of TLR4, TRIF deletion may contribute to the
survival of RGCs by microglial inactivation to some
extent. A similar neurotoxic role for microglia-mediated
fundamental injury or repair was described by Nguyen
et al. [37]. Recently, TLR4, MyD88, or TICAM1 ablation
were reported to promote proliferation in the post-natal
mammalian retina [37]. However, no study has reported
that TRIF deletion promotes axon regeneration of adult
RGCs by microglial inactivation. Therefore, our results
p r o v i d es o m en e wd a t af o rn e u r o i m m u n o l o g i c a la n d
neuroinflammatory aspects.
Recent studies have identified novel roles for TLRs in
the CNS and peripheral nervous system [38]. Down-
stream of TLR3 and TLR4, activation of TRIF is essen-
tial for the MyD88-independent pathway [39]. Similarly,
both IFN-b mRNA and protein were reduced in the
trif
-/- compared with the WT microglia when stimulated
by RGC lesions in vitro.I F N - b is one of the factors
released by microglia, and is used as a clinical treatment
for prevention of relapse in all subtypes of multiple
sclerosis (MS) [40]. However, it may severely exacerbate
optic-spinal MS in the neuromyelitis optica spectrum,
amplifying CNS inflammation, and exacerbating the dis-
ease [40-43]. To our knowledge, IFN-b was reduced in
the study, allowing promotion of RGC axon regenera-
tion by TRIF deficiency and a neutralizing antibody,
which supports the work of Shimizu et al. [42]. IFN-b is
a factor released downstream, and is activated by an
intracellular mechanism and upstream receptors in
microglia. Several lines of evidence suggest that
upstream of the pro-inflammatory release, the microglial
innate immunological responses are involved in micro-
glial activation [44,45]. Furthermore, there remains a
possibility that TRIF deficiency may contribute to IFN-a
delivery, and the release of IFN-b may trigger other pro-
inflammatory genes that have dual roles in benefiting or
impairing neurons during different time periods, exert-
ing a beneficial or detrimental effect on the retina and
ON regeneration. Thus, a further challenge is to clarify
other upstream and intracellular mechanisms, for exam-
ple TLR3 or TLR4 signaling, and IF3 activation.
As described previously [46,47], overexpression of TRIF
causes activation of the NF-B promoter in 293 cells and
the IFN-b promoter. In our study, expression of TRIF gra-
dually increased at 1, 3 and 7 dPC in the WT group (Fig-
ure 1A). Compared with the WT group, expression of
TBK1, IKKε,a n dN F - B decreased in the trif
-/- group,
indicating that the microglial activation of TBK1, IKKε,
and NF-B in response to pre-stimulation by injured
RGCs is TRIF-dependent. TRIF-mutant mice were defec-
tive in TLR3- and TLR4-mediated inflammatory responses
[48], supporting our observation that TRIF deficiency lim-
its the inflammatory effect on RGCs via TBK1, IKKε, and
A
B
C
Figure 7 TIR-domain-containing adapter-inducing interferon-b
(TRIF) deficiency attenuates microglial inflammatory factor
release. Real-time reverse transcriptase (RT)-PCR and ELISA results of
wild-type (WT) and trif
-/- microglia pre-stimulated by injured RGCs in
a transwell system to identify changes of inflammatory factors. (A-F)
Measured by real-time RT PCR; (G-K) measured by ELISA. (A) Bar
graphs showing interferon (IFN)-b mRNA expressed in the control,
and at 12, 24, and 36 hours in WT and trif
-/- microglia by real-time
RT-PCR. Significant differences were seen at 36 hours in microglia
pre-stimulated with injured RGCs. (B) Interleukin (IL)-1b mRNA
expressed in the WT and trif
-/- groups. At 12 hours, IL-1b mRNA
expression was higher in the trif
-/- than in the WT group; however,
at 24 and 36 hours, it was higher in the WT than in the trif
-/- group.
(C) At 24 hours and 36 hours, tumor necrosis factor (TNF)-a was
upregulated to a greater extent in the WT group. (D) IL-6 was
significantly higher in the WT than in the trif
-/- group at 24 and 36
hours. (E) IL-17 was upregulated at 36 hours in the WT. (F) Inducible
nitric oxide synthase (iNOS) increased from 12 to 36 hours in the
WT. Similar to the PCR results, (G) IFN-b release increased markedly
at 24 and 36 hours. (H) IL-1b had a greater increase at 24 and 36
hours in the WT than in the trif
-/- group; however, it was lower at
12 hours. (I) TNF-a concentration was significantly increased in the
WT at 24 and 36 hours compared with the trif
-/- group. (J) IL-6
concentration was significantly increased in the WT at 24 and 36
hours compared with the trif
-/- group. (K) IL-17 concentration was
significantly increased in the WT at 12, 24, and 36 hours compared
with trif
-/- group. Experiments were performed in triplicate. n = 3, *P
<0.05 vs. increase relative to the trif
-/-group (WT group at the same
time point). b-actin mRNA was used as an internal control.
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Page 11 of 15NF-B signaling pathways. However, other signaling path-
ways may be involved in the activation of NF-B signaling,
which needs further investigation.
IL-1b output depends on the activation of NF-B,
leading to some neurotoxicity in the CNS [49]. In our
results, the trif
-/- group had higher IL-1b expression in
the early phase of stimulation compared with the WT
group, but at a later stage, this decreased suddenly. This
is an early-phase activation by MyD88 compensation.
The pulse, not the constant release of IL-1b,w h i c h
Figure 8 Microglial cells in retinal sections at post-crush days 7 and 14 (7dPC and 14dPC). Microglia in retinal sections were different
between the WT and trif-/- groups at 7dPC and 14dPC. (A) In the WT group, microglia were located in the ganglion cell layer (GCL) and the
inner plexiform layer (IPL). After stimulation by ON injury, more microglia were located in the GCL and IPL, and had a ramified and dotted shape
at 7dPC. More microglia with a dotted shape and short processes were located in the GCL and IPL at 14dPC. (B) In the trif-/- group, the
microglia located in the GCL and IPL had a ramified shape. Scale bar = 20 &#956m. Scale bar (in box) = 10 &#956m. GCL, ganglion cell layer; IPL,
inner plexiform layer.
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Page 12 of 15decreased significantly at 24 and 36 hours, may not sig-
nificantly influence the survival of RGCs.
IL-6 and IL-17 expression was different between WT
and trif
-/- microglial cells pre-stimulated by injured
RGCs. IL-6 belongs to the neuropoietic cytokine family,
and is a multifunctional cytokine that regulates cell dif-
ferentiation, growth, and survival in a variety of diseases
[50,51]. Induced IL-6 accompanied by TNF-a and IFN-g
probably contributes to the lower toxicity seen with
conditioned medium collected from retinas incubated
with the Rho-kinase inhibitor H1152p [52]. Microglial
IL-17 is produced in response to IL-23 and IL-1b,a n d
contributes to autoimmune diseases in the CNS [53].
Similarly, we found that in a co-culture system of
microglial cells and RGCs, the mRNA and protein levels
of TNF-a, IL-6, and IL-17 were significantly higher in
the WT group than in the trif
-/- group. This suggests
that microglial TRIF gene deletion induces fewer neuro-
toxic factors and inflammatory responses with harmful
effects on axonal regeneration. A previous study by Siva-
kumar et al. [54] identified microglial inflammation in a
hypoxic neonatal retina model, which is consistent with
our results, performed in a co-culture system of micro-
glial cells and RGCs.
The appearance of the microglia in the healthy mature
tissues of brain, spinal cord, and retina suggest both a
similarities and dissimilarities between these tissues.
CD11c
+CD45
loF4/80
+ cells in retina have been identified
as microglia, which were considered initially to have
antigen-presenting capacity both in retina and in brain
[55]. Similar to brain, retinal microglia express IL-27
and IL-10 to control the severity or duration of inflam-
mation in the CNS [56]. In response to injury, the
immunoproteasome is significantly upregulated in both
retina and brain. However, the expression of the immu-
noproteasome, which generates immunogenic peptides
for antigen presentation, is approximately twofold higher
in retina than in normal brain [57,58]. In scrapie-
induced neurodegeneration, the activation and function
of microglia under the control of the PrP promoter
(tg7) and the neuron-specific enolase promoter (tgNSE)
are clearly different in the retina and brain [59].
With regard to human disease, traumatic optic neuro-
pathy (TON) is one of the most common neuropathies,
affecting an increasing number of people worldwide and
leading to loss of neural cells of the eyes. Although
recent advances in treatment can now slow its progres-
sion, many people with TON still experience an irrever-
sible loss of vision [60,61]. ON and retinal research may
provide insights into CNS disease. Regulation of inflam-
mation could provide strong evidence for attenuating
the injury to protect the ON and retina from
neuropathy.
Upstream TRIF signaling is involved in the initiation
of inflammatory factor release, which activates and
recruits microglia in response to RGC axon injury via
the TBK1-IKKε-NF-B signaling pathways. Overexpres-
sion of TRIF and NF-B is likely to induce neurotoxicity
[46,47].
Conclusions
In summary, our findings suggest a specific upstream
target for potential therapeutic interventions aiming at
inhibition of TRIF-induced inflammatory responses.
TRIF deficiency results in protection of neurons from
microglial neurotoxicity, attenuates the release of
inflammatory factors, and promotes axon regeneration.
As innate immunity is involved in various neurodegen-
erative diseases, further investigation of novel treatment
strategies that interfere with the activation of inflamma-
tory responses after retinal injury remains an important
area of research.
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